Skip to main content
. 2022 Oct 17;107(5):1060–1065. doi: 10.4269/ajtmh.22-0421

Table 1.

Clinical characteristics, and maternal and perinatal outcomes among women with and without a COVID-19 diagnosis

Characteristic and outcome COVID-19 group Control group P value*
Maternal age, years; median (IQR) 29.85 (10) 29.53 (9) 0.751
Parity, n/N (%)
 Nulliparous 35/84 (41.7) 22/88 (25) 0.013
 Primiparous 21/84 (25) 31/88 (35.2) 0.144
 Multiparous 28/84 (41.7) 35/88 (39.8) 0.844
Comorbidities, n/N (%) 34/84 (40.5) 35/88 (39.8) 0.920
Obstetric ultrasound abnormalities, n/N (%) 11/47 (23.4) 1/53 (1.9) < 0.001
Cesarean delivery, n/N (%) 52/80 (65) 50/84 (59.5) 0.470
Preterm birth (< 37 weeks), n/N (%) 15/80 (18.8) 6/84 (7.1) 0.026
Small for gestational age, n/N (%) 7/80 (8.8) 2/84 (2.4) 0.073
Apgar score at 5 min < 7, n/N (%) 6/77 (7.8) 4/84 (4.8) 0.426
Postpartum depression,§ n/N (%) 18/40 (45) 12/61 (19.7) 0.006
Gestational age at birth, weeks; median (IQR) 38.2 (2.1) 38.7 (1.9) 0.054
Birthweight, g; mean (SD) 3,176.4 (519.5) 3,266.5 (461.2) 0.502

IQR = interquartile range.

*

The χ2 test or Fisher’s exact test was used for categorical variables; Student’s t-test or the Mann–Whitney U test was used for continuous variables.

Patients without comorbidities in both groups and at least 2 ultrasounds performed by the same professional.

Less than the 10th percentile (International INTERGROWTH-21st Newborn Size Standards).

§

Edinburgh Postnatal Depression Scale score ≥ 11.